Deferred Income Tax Liabilities, Net of LIFECORE BIOMEDICAL, INC. \DE\ from 26 May 2019 to 24 Nov 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 26 May 2019 to 24 Nov 2024.
  • LIFECORE BIOMEDICAL, INC. \DE\ Deferred Income Tax Liabilities, Net for the quarter ending 24 Nov 2024 was $552,000, a 33% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $552,000 +$136,000 +33% 24 Nov 2024 10-Q 02 Jan 2025 2025 Q2
Q3 2024 $443,000 -$13,000 -2.9% 25 Aug 2024 10-Q 04 Oct 2024 2025 Q1
Q2 2024 $543,000 +$163,000 +43% 26 May 2024 10-Q 02 Jan 2025 2025 Q2
Q1 2024 $607,000 +$527,000 +659% 25 Feb 2024 10-Q 09 Aug 2024 2024 Q3
Q4 2023 $416,000 +$406,000 +4060% 26 Nov 2023 10-Q 09 Aug 2024 2024 Q2
Q3 2023 $456,000 +$332,000 +268% 27 Aug 2023 10-Q 09 Aug 2024 2024 Q1
Q2 2023 $380,000 +$254,000 +202% 28 May 2023 10-K 26 Aug 2024 2024 FY
Q1 2023 $80,000 -$716,000 -90% 26 Feb 2023 10-K 20 Mar 2024 2023 FY
Q4 2022 $10,000 -$1,191,000 -99% 27 Nov 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 $124,000 -$3,825,000 -97% 28 Aug 2022 10-K 20 Mar 2024 2023 FY
Q2 2022 $126,000 -$5,849,000 -98% 29 May 2022 10-K 20 Mar 2024 2023 FY
Q1 2022 $796,000 -$5,308,000 -87% 27 Feb 2022 10-K 20 Mar 2024 2023 FY
Q4 2021 $1,201,000 -$5,430,000 -82% 28 Nov 2021 10-K 20 Mar 2024 2023 FY
Q3 2021 $3,949,000 -$4,928,000 -56% 29 Aug 2021 10-K 20 Mar 2024 2023 FY
Q2 2021 $5,975,000 -$7,613,000 -56% 30 May 2021 10-K 20 Mar 2024 2023 FY
Q1 2021 $6,104,000 -$5,558,000 -48% 28 Feb 2021 10-K 20 Mar 2024 2023 FY
Q4 2020 $6,631,000 -$10,416,000 -61% 29 Nov 2020 10-K 20 Mar 2024 2023 FY
Q3 2020 $8,877,000 -$8,809,000 -50% 30 Aug 2020 10-K 20 Mar 2024 2023 FY
Q2 2020 $13,588,000 -$5,805,000 -30% 31 May 2020 10-K 29 Jul 2021 2021 FY
Q1 2020 $11,662,000 23 Feb 2020 10-Q 03 Apr 2020 2020 Q3
Q4 2019 $17,047,000 24 Nov 2019 10-Q 02 Jan 2020 2020 Q2
Q3 2019 $17,686,000 25 Aug 2019 10-Q 03 Oct 2019 2020 Q1
Q2 2019 $19,393,000 26 May 2019 10-K 14 Aug 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.